Matches in SemOpenAlex for { <https://semopenalex.org/work/W15573899> ?p ?o ?g. }
- W15573899 endingPage "206" @default.
- W15573899 startingPage "195" @default.
- W15573899 abstract "Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), also known as Apo2L, is a member of the TNF superfamily (TNFSF) of cytokines. TRAIL gained much attention during the past decade due to the demonstration of its therapeutic potential as a tumor-specific apoptosis inducer. TRAIL was identified as a protein with high homology to other members of the TNF cytokine family, especially to the ligand of Fas/Apo-1 (CD95), CD95L (FasL/APO-1L). TRAIL has been shown to induce apoptosis selectively in many tumor cell lines without affecting normal cells and tissues, making TRAIL itself as well as agonists of the two human receptors of TRAIL which can submit an apoptotic signal, TRAIL-R1 (DR4) and TRAIL-R2 (DR5), promising novel biotherapeutics for cancer therapy. An increasing number of publications now shows that TRAIL resistance in primary human tumor cells will have to be overcome and that sensitization to TRAIL-induced apoptosis will be required in many cases. Therefore, it will also be instrumental to develop suitable diagnostic tests to identify patients who will benefit from TRAIL-based novel anticancer therapeutics and those who will not. Interestingly, the first clinical results even in monotherapy with TRAIL as well as various agonistic TRAIL receptor-specific antibodies have shown encouraging results. This chapter provides a compact overview on the biochemistry of the TRAIL/TRAIL-R system, the physiological role of TRAIL and its receptors and the results of clinical trials with TRAIL and various TRAIL-R agonistic antibodies." @default.
- W15573899 created "2016-06-24" @default.
- W15573899 creator A5010299907 @default.
- W15573899 creator A5012050778 @default.
- W15573899 creator A5026927497 @default.
- W15573899 creator A5057725652 @default.
- W15573899 creator A5085552716 @default.
- W15573899 date "2009-01-01" @default.
- W15573899 modified "2023-09-26" @default.
- W15573899 title "TRAIL and Other TRAIL Receptor Agonists as Novel Cancer Therapeutics" @default.
- W15573899 cites W1484817497 @default.
- W15573899 cites W1519814596 @default.
- W15573899 cites W1527985047 @default.
- W15573899 cites W1549882456 @default.
- W15573899 cites W1827525224 @default.
- W15573899 cites W1966798559 @default.
- W15573899 cites W1967554392 @default.
- W15573899 cites W1967637444 @default.
- W15573899 cites W1969893319 @default.
- W15573899 cites W1971902136 @default.
- W15573899 cites W1973848893 @default.
- W15573899 cites W1986222655 @default.
- W15573899 cites W1991455654 @default.
- W15573899 cites W1996670401 @default.
- W15573899 cites W2002353852 @default.
- W15573899 cites W2010913093 @default.
- W15573899 cites W2012166934 @default.
- W15573899 cites W2012668596 @default.
- W15573899 cites W2016417780 @default.
- W15573899 cites W2016770760 @default.
- W15573899 cites W2016979416 @default.
- W15573899 cites W2017825229 @default.
- W15573899 cites W2018004937 @default.
- W15573899 cites W2018667424 @default.
- W15573899 cites W2021323060 @default.
- W15573899 cites W2024550870 @default.
- W15573899 cites W2026537503 @default.
- W15573899 cites W2031949901 @default.
- W15573899 cites W2033150364 @default.
- W15573899 cites W2036897993 @default.
- W15573899 cites W2038273601 @default.
- W15573899 cites W2042263670 @default.
- W15573899 cites W2043868011 @default.
- W15573899 cites W2059030251 @default.
- W15573899 cites W2060960232 @default.
- W15573899 cites W2064810389 @default.
- W15573899 cites W2067298582 @default.
- W15573899 cites W2071909988 @default.
- W15573899 cites W2074536358 @default.
- W15573899 cites W2082579581 @default.
- W15573899 cites W2085591135 @default.
- W15573899 cites W2087057471 @default.
- W15573899 cites W2087423421 @default.
- W15573899 cites W2089082314 @default.
- W15573899 cites W2092058648 @default.
- W15573899 cites W2092508425 @default.
- W15573899 cites W2093157233 @default.
- W15573899 cites W2098536205 @default.
- W15573899 cites W2102828763 @default.
- W15573899 cites W2105186639 @default.
- W15573899 cites W2105441981 @default.
- W15573899 cites W2106284224 @default.
- W15573899 cites W2108902725 @default.
- W15573899 cites W2112327309 @default.
- W15573899 cites W2113505777 @default.
- W15573899 cites W2118971842 @default.
- W15573899 cites W2123123035 @default.
- W15573899 cites W2130407652 @default.
- W15573899 cites W2136466348 @default.
- W15573899 cites W2138523965 @default.
- W15573899 cites W2146825351 @default.
- W15573899 cites W2148258332 @default.
- W15573899 cites W2150758813 @default.
- W15573899 cites W2151642508 @default.
- W15573899 cites W2158662605 @default.
- W15573899 cites W2162275000 @default.
- W15573899 cites W2162653594 @default.
- W15573899 cites W2168589849 @default.
- W15573899 cites W2169295136 @default.
- W15573899 cites W2170157230 @default.
- W15573899 cites W2328332463 @default.
- W15573899 cites W4235493536 @default.
- W15573899 cites W4243464755 @default.
- W15573899 doi "https://doi.org/10.1007/978-0-387-89520-8_14" @default.
- W15573899 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19760076" @default.
- W15573899 hasPublicationYear "2009" @default.
- W15573899 type Work @default.
- W15573899 sameAs 15573899 @default.
- W15573899 citedByCount "85" @default.
- W15573899 countsByYear W155738992012 @default.
- W15573899 countsByYear W155738992013 @default.
- W15573899 countsByYear W155738992014 @default.
- W15573899 countsByYear W155738992015 @default.
- W15573899 countsByYear W155738992016 @default.
- W15573899 countsByYear W155738992017 @default.
- W15573899 countsByYear W155738992018 @default.
- W15573899 countsByYear W155738992019 @default.
- W15573899 countsByYear W155738992020 @default.